Get the latest Science News and Discoveries

Preoperative dual immunotherapy combination shows promising activity in high-risk early-stage HER2-negative breast cancer - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer - EurekAlert!

Deep, Calming Breaths May Actually Increase Risk-Taking Behavior

Low-Sugar Diet Early in Life Linked to 46% Lower Alzheimer's Risk